Rexulti, the first drug to relieve Alzheimer's emotions - TimesKuwait

The US Food and Drug Administration (FDA) has granted fast-track approval of the first drug aimed at relieving the emotions associated with Alzheimer’s disease. The FDA published, on its official website, a statement confirming the approval of Otsuka Pharmaceutical Company and Lundbeck, producers of oral Rexulti tablets to relieve the emotions associated with Alzheimer’s disease, […]

FDA approves first drug meant to ease Alzheimer's-linked agitation

FDA Approves First Drug for Treating Agitation in Alzheimer's Patients - MedCity News

Otsuka, Lundbeck's Rexulti scores new Alzheimer's use

REXULTI® (brexpiprazole) Agitation associated with dementia due to Alzheimer's disease

First-Ever Drug for Alzheimer's Agitation, Brexpiprazole, Nears Finish Line

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

Lundbeck, Otsuka drug cut agitation in Alzheimer's patients

Positive Data for First and Only Treatment Approved for Agitation in Alzheimer Dementia

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

FDA clears Rexulti as first drug for Alzheimer's agitation